Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

康士得 - NMPA Drug Approval Details

Approvals/NMPA/Bicalutamide Tablets

Approved

化学药品

Bicalutamide Tablets

ASTRAZENECA UK LIMITED🇨🇳 National Medical Products Administration

Approval Date: Nov 30, 2023
Approval ID: 8WHZLFCvSKC
Company: ASTRAZENECA UK LIMITED
Type: 化学药品

Approval Details

Approval Id: 8WHZLFCvSKC
Approval Number: 国药准字HJ20140719
Generic Name: 比卡鲁胺片
Generic Name En: Bicalutamide Tablets
Trade Name: 康士得
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 50mg
Reg Date: 2023-11-30
Expired Date: 2028-11-29
Company Name: ASTRAZENECA UK LIMITED
Production Company Name: Corden Pharma Gmbh
Company Detail Path: /organization/astrazeneca-uk-limited
Production Company Detail Path: /organization/corden-pharma-gmbh

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Nov 30, 2023

Approval ID

8WHZLFCvSKC

Type

化学药品

Back to NMPA Approvals